(R)-3-(2-(5-amino-1,3,4-thiadiazol-2-ylthio)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid

ID: ALA4636953

PubChem CID: 76900728

Max Phase: Preclinical

Molecular Formula: C13H13BN4O5S2

Molecular Weight: 380.22

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nnc(SCC(=O)N[C@H]2Cc3cccc(C(=O)O)c3OB2O)s1

Standard InChI:  InChI=1S/C13H13BN4O5S2/c15-12-17-18-13(25-12)24-5-9(19)16-8-4-6-2-1-3-7(11(20)21)10(6)23-14(8)22/h1-3,8,22H,4-5H2,(H2,15,17)(H,16,19)(H,20,21)/t8-/m0/s1

Standard InChI Key:  IUNQEXJRZWMEMG-QMMMGPOBSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    8.8856   -3.7997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5953   -3.3903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5925   -2.5676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8839   -2.1624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1776   -3.3908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1817   -2.5712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4779   -2.1601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7655   -2.5641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7614   -3.3836    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    7.4697   -3.7993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0604   -2.1510    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3501   -2.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6450   -2.1419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3449   -3.3722    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9347   -2.5460    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2297   -2.1328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8854   -4.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1776   -5.0253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5931   -5.0257    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0512   -3.7880    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1503   -1.3174    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3520   -1.1424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9389   -1.8475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4819   -2.4582    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.1257   -1.9278    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  1
 11 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
  1 17  1  0
 17 18  1  0
 17 19  2  0
  9 20  1  0
 16 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 16  1  0
 23 25  1  0
M  END

Associated Targets(non-human)

blaKPC-2 Class A carbapenemase KPC-2 (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KPC-2 Beta-lactamase (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 380.22Molecular Weight (Monoisotopic): 380.0420AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Hecker SJ, Reddy KR, Lomovskaya O, Griffith DC, Rubio-Aparicio D, Nelson K, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Parkinson J, Totrov M, Boyer SH, Glinka TW, Pemberton OA, Chen Y, Dudley MN..  (2020)  Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases.,  63  (14): [PMID:32150407] [10.1021/acs.jmedchem.9b01976]

Source